Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:30 pm Sale | 2025-06-30 | 13G | Fate Therapeutics, Inc. FATE | Schonfeld Strategic Advisors LLC | 937,521 0.820% | -6,856,992 (-87.97%) | Filing History |
| 2025-08-14 11:30 am Sale | 2025-06-30 | 13G | Fate Therapeutics, Inc. FATE | GOLDMAN SACHS GROUP INC GS | 2,274,020 2.000% | -6,213,200 (-73.21%) | Filing History |
| 2025-07-29 1:13 pm Sale | 2025-06-30 | 13G | Fate Therapeutics, Inc. FATE | VANGUARD GROUP INC | 8,766,764 7.640% | -526,599 (-5.67%) | Filing History |
| 2025-07-03 4:01 pm Purchase | 2025-07-02 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 17,941,579 14.900% | 124,945 (+0.70%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Fate Therapeutics, Inc. FATE | Schonfeld Strategic Advisors LLC | 7,794,513 6.800% | 7,794,513 (New Position) | Filing History |
| 2025-05-09 12:27 pm Purchase | 2025-03-31 | 13G | Fate Therapeutics, Inc. FATE | GOLDMAN SACHS GROUP INC GS | 8,487,220 7.400% | 8,487,220 (New Position) | Filing History |
| 2025-04-23 8:39 pm Sale | 2025-03-31 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 7,852,183 6.900% | -2,621,067 (-25.03%) | Filing History |
| 2024-12-26 9:00 pm Purchase | 2024-12-20 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 17,816,634 14.900% | 197,539 (+1.12%) | Filing History |
| 2024-11-14 7:50 pm Sale | 2024-09-30 | 13G | Fate Therapeutics, Inc. FATE | Point72 Asset Management, L.P. | 0 0.000% | -4,945,146 (Position Closed) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 10,473,250 9.200% | 0 (Unchanged) | Filing History |
| 2024-10-25 9:37 pm Purchase | 2024-10-10 | 13G | Fate Therapeutics, Inc. FATE | Boxer Capital Management LLC | 4,960,910 4.400% | 4,960,910 (New Position) | Filing History |
| 2024-10-21 4:11 pm Sale | 2024-09-30 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 10,473,250 9.200% | -739,566 (-6.60%) | Filing History |
| 2024-03-25 5:15 pm Purchase | 2024-03-21 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 17,619,095 14.900% | 2,569,256 (+17.07%) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | Fate Therapeutics, Inc. FATE | VANGUARD GROUP INC | 9,293,363 9.430% | -642,679 (-6.47%) | Filing History |
| 2024-02-12 6:06 pm Purchase | 2024-01-31 | 13G | Fate Therapeutics, Inc. FATE | Boxer Capital LLC | 6,171,000 6.300% | 6,171,000 (New Position) | Filing History |
| 2024-02-09 6:19 pm Sale | 2024-02-07 | 13G | Fate Therapeutics, Inc. FATE | Capital World Investors | 0 0.000% | -5,591,517 (Position Closed) | Filing History |
| 2024-01-25 4:19 pm Purchase | 2024-01-24 | 13G | Fate Therapeutics, Inc. FATE | Point72 Asset Management, L.P. | 4,945,146 5.000% | 4,945,146 (New Position) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Fate Therapeutics, Inc. FATE | BlackRock Inc. BLK | 11,212,816 11.400% | 1,486,921 (+15.29%) | Filing History |
| 2024-01-22 1:46 pm Sale | 2023-12-31 | 13G | Fate Therapeutics, Inc. FATE | STATE STREET CORP STT | 1,861,919 1.890% | -410,006 (-18.05%) | Filing History |
| 2023-12-28 4:53 pm Sale | 2023-12-26 | 13D | Fate Therapeutics, Inc. FATE | Redmile Group, LLC | 15,049,839 14.900% | -21,257 (-0.14%) | Filing History |